Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Barbara Ryan Insider Profile
4 Followers
Barbara Ryan, Director at INVO Bioscience, holds 86.62K shares in MiNK Therapeutics (Ticker: INKT), holds 22.99K shares in INVO Bioscience (Ticker: INVO), holds ― shares in Azitra Inc (Ticker: AZTR).
Barbara Ryan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Barbara Ryan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Barbara Ryan
Barbara Ryan's Trading History
INVO Bioscience
Jun 03, 2022
Director
Informative Buy
10.00K
$24.60K
MiNK Therapeutics
Mar 05, 2024
Director
Uninformative Buy
17.75K
$90.08K
Azitra Inc
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Barbara Ryan's performance on stock
You May Also Like
Barbara Ryan insider profile FAQ
What is the percentage of profitable transactions made by Barbara Ryan?
The percentage of profitable transactions made by Barbara Ryan is ―.
What is the average return per transaction made by Barbara Ryan?
The average return per transaction made by Barbara Ryan is ―.
What stocks does Barbara Ryan hold?
Barbara Ryan holds: INVO, INKT, AZTR stocks.
What was Barbara Ryan’s latest transaction?
Barbara Ryan latest transaction was an Uninformative Buy of $17.75K.
What was Barbara Ryan's most profitable transaction?
Barbara Ryan’s most profitable transaction was an Informative Buy of INVO stock on June 3, 2022. The return on the trade was -76.40%.
What is Barbara Ryan's role in INVO Bioscience?
Barbara Ryan's role in INVO Bioscience is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.